Table 3:
CAC Score Group |
N (%) | Unadjusted HR (95% CI) |
Model 1 HR (95% CI)* |
Model 2 HR (95% CI)† |
---|---|---|---|---|
CHD death | ||||
ASCVD risk <10% | ||||
CAC=0 | 9 (25) | 1.0 | 1.0 | 1.0 |
CAC 1–99 | 9 (25) | 1.29 (0.51 – 3.24) | 1.33 (0.52 – 3.38) | 1.30 (0.52 – 3.30) |
CAC 100–399 | 6 (16.7) | 2.38 (0.85 – 6.67) | 2.51 (0.87 – 7.23) | 2.39 (0.85 – 6.70) |
CAC ≥400 | 12 (33.3) | 8.02 (3.38 – 19.05) | 8.60 (3.42 – 21.65) | 8.11 (3.24 – 20.29) |
ASCVD risk ≥10% | ||||
CAC=0 | 9 (5.3) | 1.0 | 1.0 | 1.0 |
CAC 1–99 | 22 (12.9) | 1.10 (0.51 – 2.38) | 1.05 (0.48 – 2.30) | 1.03 (0.47 – 2.24) |
CAC 100–399 | 35 (20.5) | 2.02 (0.97 – 4.20) | 1.70 (0.80 – 3.61) | 1.60 (0.76 – 3.40) |
CAC ≥400 | 105 (61.4) | 4.91 (2.49 – 9.68) | 3.74 (1.81 – 7.74) | 3.36 (1.63 – 6.94) |
CVD death | ||||
ASCVD risk <10% | ||||
CAC=0 | 25 (28.4) | 1.0 | 1.0 | 1.0 |
CAC 1–99 | 25 (28.4) | 1.28 (0.73,2.22) | 1.36 (0.76,2.44) | 1.32 (0.74,2.36) |
CAC 100–399 | 14 (15.9) | 1.99 (1.03,3.83) | 2.16 (1.09,4.27) | 2.00 (1.01,3.95) |
CAC ≥400 | 24 (27.3) | 5.75 (3.27,10.09) | 6.46 (3.39,12.32) | 5.92 (3.11,11.26) |
ASCVD risk ≥10% | ||||
CAC=0 | 17 (5.3) | 1.0 | 1.0 | 1.0 |
CAC 1–99 | 54 (16.8) | 1.43 (0.83,2.46) | 1.43 (0.83,2.47) | 1.4 (0.81,2.43) |
CAC 100–399 | 76 (23.7) | 2.33 (1.38,3.94) | 2.02 (1.19,3.45) | 1.93 (1.13,3.30) |
CAC ≥400 | 174 (54.2) | 4.37 (2.66,7.18) | 3.52 (2.09,5.90) | 3.28 (1.95,5.51) |
N (%) represent number of events in each category.
Model 1 adjusted for age and sex.
Model 2 adjusted for age, sex, hyperlipidemia, smoker, family history of CHD and diabetes.
ASCVD indicates atherosclerotic cardiovascular disease; CAC, coronary artery calcium; CHD, coronary heart disease; CI, confidence interval; CVD, cardiovascular disease; HR, hazard ratio.